Latest Pulmonology Articles

• Expanding the Evidence and Indications for Thrombectomy in Ischemic Stroke October 23, 2026
  In 2015, pivotal randomized, controlled trials established the benefit of endovascular treatment for acute ischemic stroke due to a large-vessel occlusion.1,2 The trials showed a major clinical benefit in patients presenting with relatively standard stroke features: large-vessel occlusion in the anterior circulation; relevant clinical neurologic deficit; short time...
  Gaultier Marnat
• Mechanical Thrombectomy 24 to 72 Hours after Large-Vessel Ischemic Stroke October 23, 2026
  Among patients with salvageable tissue 24 to 72 hours after stroke, physical function at 90 days was better with thrombectomy than with medical care alone, but intracerebral hemorrhage and death were more common with thrombectomy.
  Pengfei Yang, Hongjian Shen, Tingyu Yi, Pengfei Xing, Junfeng Su, Changming Wen, Weiyi Zhong, Qiang Li, Yunting He, Xiaoying Chen, Song He, Xinwen Ren, Shoujiang You, Yang Zhao, Borui Wang, Yongxin Zhang, Lei Chen, Xuan Zhu, Minmin Zhang, Ying Yu, Yi Jiang, Yina Wu, Chuanchuan Wang, Xiaoxi Zhang, Wenjin Yang, Fang Shen, Lijun Wang, Meihua Huyan, Bing Tian, Wenhuo Chen, Guangxian Nan, Liyong Zhang, Huaizhang Shi, Jianfeng Han, Tong Li, Fan Zhang, Ming Wei, Chenghua Xu, Ya Peng, Jun Sun, Shouchun Wang, Hongxing Han, Hao Wang, Wenqiang Cai, Meng Zhang, Congguo Yin, Guangsen Cheng, Rong Yin, Quanbin Zhang, Guodong Xiao, Yunfeng Zhang, Sheng Liu, Hui Li, Lei Zhang, Zifu Li, Yu Zhou, Rui Zhao, Qiang Li, Charles B.L.M. Majoie, Lili Song, Yongwei Zhang, Craig S. Anderson, Jianmin Liu, the LATE-MT Investigators*
• Trial of Endovascular Therapy for Mild Stroke with Large-Vessel Occlusion October 23, 2026
  Among patients with mild stroke from large-vessel occlusion, 69.4% had a favorable functional outcome at 90 days with endovascular therapy plus medical management, as compared with 50.0% with medical management alone.
  Jianmin Liu, Tingyu Yi, Pengfei Xing, Meihua Wu, Liyong Zhang, Tuanyuan Zheng, Mingzhu Huang, Yanmin Wu, Hao Wang, Guoyong Zeng, Jinglun Li, Ya Peng, Yueqi Zhu, Yibin Fang, Xueli Cai, Jun Luo, Yuanbiao Lei, Hao Qin, Pu Fang, Yamei Tang, Guangxiong Yuan, En Wang, Xiongjun He, Xiongwei Lu, Zhentao Li, Bo Lei, Hua Cao, Xinguang Yang, Chenghua Xu, Meixia Shang, Craig S. Anderson, Zeguang Ren, Pengfei Yang, Wenhuo Chen, the MILD-MT Investigators*